Correlation of serum TNF-α levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease

American Journal of Clinical Pathology

Volumn 127, Issue 6, 2007, Pages 954-960

  Manco, Melania ^a   Marcellini, Matilde ^a   Giannone, Germana ^a   Nobili, Valerio ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Inflammation; Insulin resistance; Leptin; NAFLD; NASH; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Receiver operating characteristic curves; TNF ; Tumor necrosis factor

Indexed keywords

ALKALINE PHOSPHATASE; LEPTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER INJURY; MALE; NONALCOHOLIC FATTY LIVER; NONALCOHOLIC FATTY LIVER DISEASE SCORE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SCORING SYSTEM; UNIVARIATE ANALYSIS; VALIDATION PROCESS; BLOOD; CHILD; CLINICAL TRIAL; FATTY LIVER; LIVER; LIVER FUNCTION TEST; PATHOLOGY; PREDICTION AND FORECASTING; ROC CURVE; VALIDATION STUDY;

ADOLESCENT; ALKALINE PHOSPHATASE; CHILD; FATTY LIVER; FEMALE; HUMANS; LEPTIN; LIVER; LIVER FUNCTION TESTS; MALE; PREDICTIVE VALUE OF TESTS; ROC CURVE; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34250632770     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/6VJ4DWGYDU0XYJ8Q     Document Type: Article

References (37)

1. Franzese A, Vajro P, Argenziano A, et al. Liver involvement in obese children: ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci. 1997;42:1428-1432.
2. Nobili V, Marcellini M, Devito R, et al. Nonalcoholic fatty liver disease in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology. 2006;44:458-465.
3. Fontana RJ, Lok AS. Noninvasive monitoring of patients with chronic hepatitis C. Hepatology. 2002;36(5 suppl 1):S57-S64.
4. Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med. 2000;343:1467-1476.
5. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology. 1998;114:842-845.
6. Ding WX, Yin XM. Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury. J Cell Mol Med. 2004;8:445-454.
7. Pessayre D, Berson A, Fromenty B, et al. Mitochondria in steatohepatitis. Semin Liver Dis. 2001;21:57-69.
8. Arkan MC, Hevener AL, Greten FR, et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med. 2005;11:191-198.
9. Crespo J, Cayon A, Fernandez-Gil P, et al. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology. 2001;34:1158-1163.
10. Tang M, Potter JJ, Mezey E. Leptin enhances the effect of transforming growth factor beta in increasing type I collagen formation. Biochem Biophys Res Commun. 2002;297:906-911.
11. Saxena NK, Saliba G, Floyd JJ, et al. Leptin induces increased alpha2 (I) collagen gene expression in cultured rat hepatic stellate cells. J Cell Biochem. 2003;89:311-320.
12. Vettor R, Milan G, Rossato M, et al. Review article: adipocytokines and insulin resistance. Aliment Pharmacol Ther. 2005;22(suppl 2):3-10.
13. Kleiner DE, Brunt EM, Van Natta M, et al, for the Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313-1321.
14. Cole TJ, Bellizzi MC, Flegal KM, et al. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320:1-6.
15. Brotons C, Ribera A, Perich RM, et al. Worldwide distribution of blood lipids and lipoproteins in childhood and adolescence: a review study. Atherosclerosis. 1998;139:1-9.
16. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555-576.
17. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-1197.
18. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
19. Matsuda M, De Fronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22:1462-1470.
20. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993;39:561-577.
21. Hanley J. The robustness of the "binormal" assumptions used in fitting ROC curves. Med Decis Making. 1988;8:197-203.
22. Altman DG. Practical Statistics for Medical Research. London, England: Chapman & Hall; 1991.
23. Day CP. From fat to inflammation. Gastroenterology. 2006;130:207-210.
24. Videla LA, Rodrigo R, Araya J, et al. Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease. Free Radic Biol Med. 2004;37:1499-1507.
25. Wigg AJ, Roberts-Thompson IC, Dymock RB, et al. The role of small bacterial overgrowth, intestinal permeability, endotoxinemia, and tumor necrosis alpha in the pathogenesis of nonalcoholic steatohepatitis. Gut. 2001;48:206-211.
26. Satapathy SK, Garg S, Chauhan R, et al. Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis. Am J Gastroenterol. 2004;99:1946-1952.
27. Kugelmas M, Hill DB, Vivian B, et al. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology. 2003;38:413-419.
28. Haukeland JW, Damas JK, Konopski Z, et al. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol. 2006;44:1167-1174.
29. Musso G, Gambino R, Durazzo M, et al. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Hepatology. 2005;42:1175-1183.
30. Mandato C, Lucariello S, Licenziati MR, et al. Metabolic hormonal oxidative, and inflammatory factors in pediatric obesity-related liver disease. J Pediatr. 2005;147:62-66.
31. Angulo P. Non-alcoholic fatty liver disease. N Engl J Med. 2002;346:1221-1231.
32. Leclercq IA, Farrell GC, Schriemer R, et al. Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol. 2003;37:206-213.
33. Fadok VA, Bratton DL, Konowal A, et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest. 1998;101:890-898.
34. Sahai A, Malladi P, Pan X, et al. Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. Am J Physiol Gastrointest Liver Physiol. 2004;287:G1035-G1043.
35. Angulo P, Alba LM, Petrovic LM, et al. Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease. J Hepatol. 2004;41:943-949.
36. Poniachik J, Csendes A, Diaz JC, et al. Increased production of IL-1 alpha in lipopolysaccharide-stimulated blood from obese patients with non-alcoholic fatty liver disease. Cytokine. 2006;33:252-257.
37. Schwimmer JB, Behling C, Newbury R, et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology. 2005;42:641-649.